Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 2Leukemia, Myeloid, Acute 2Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia 1

Interventions

fludarabine phosphate 17Mycophenolic Acid 14Cyclophosphamide 14Whole-Body Irradiation 13Tacrolimus 11Peripheral Blood Stem Cell Transplantation 11Antilymphocyte Serum 11Busulfan 9Methotrexate 8Melphalan 7Filgrastim 7Cyclosporine 7Methylprednisolone 6thymoglobulin 5Stem Cell Transplantation 5Radiotherapy 5Thiotepa 4Cytarabine 4Antibodies 4fludarabine 3Transplantation 3Psychiatric Rehabilitation 3Isotretinoin 3Granulocyte Colony-Stimulating Factor 3Flow Cytometry 3Etoposide 3Cord Blood Stem Cell Transplantation 3Clofarabine 3Azacitidine 3Alemtuzumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Myelomonocytic, Juvenile × Radioimmunotherapy × Clear all
NCT04082286 2021-06-25

Yttrium-90 Anti CD66 Monoclonal Antibody in Childhood Relapsed/Refractory Leukaemia

Great Ormond Street Hospital for Children NHS Foundation Trust

Phase 1 Completed
9 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡